BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8192463)

  • 1. beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.
    Morita K; Watanabe N; Kurata S; Kanamori M
    Antimicrob Agents Chemother; 1994 Feb; 38(2):353-5. PubMed ID: 8192463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and expression of beta-lactamase genes among Aeromonas spp.
    Walsh TR; Stunt RA; Nabi JA; MacGowan AP; Bennett PM
    J Antimicrob Chemother; 1997 Aug; 40(2):171-8. PubMed ID: 9301981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1986 Jan; 17(1):45-50. PubMed ID: 3485091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
    Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
    J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.
    Bakken JS; Sanders CC; Clark RB; Hori M
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1314-9. PubMed ID: 3264129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.
    Burgos A; Quindós G; Martínez R; Rojo P; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):413-7. PubMed ID: 2387294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of inducible beta-lactamases in Aeromonas spp.
    Iaconis JP; Sanders CC
    Antimicrob Agents Chemother; 1990 Jan; 34(1):44-51. PubMed ID: 2327760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of motile Aeromonas sp. to antimicrobial agents.
    Kaznowski A; Włodarczak K
    Zentralbl Bakteriol; 1991 Apr; 275(1):85-93. PubMed ID: 1930569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aeromonas spp. simultaneously harbouring bla(CTX-M-15), bla(SHV-12), bla(PER-1) and bla(FOX-2), in wild-growing Mediterranean mussel (Mytilus galloprovincialis) from Adriatic Sea, Croatia.
    Maravić A; Skočibušić M; Samanić I; Fredotović Z; Cvjetan S; Jutronić M; Puizina J
    Int J Food Microbiol; 2013 Sep; 166(2):301-8. PubMed ID: 23973842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypes of beta-lactam resistance in the genus Aeromonas].
    Fosse T; Giraud-Morin C; Madinier I
    Pathol Biol (Paris); 2003 Jul; 51(5):290-6. PubMed ID: 14567197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.
    Kuijper EJ; Peeters MF; Schoenmakers BS; Zanen HC
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):248-50. PubMed ID: 2496995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmids and resistance to antimicrobial agents in Aeromonas sobria and Aeromonas hydrophila clinical isolates.
    Chang BJ; Bolton SM
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1281-2. PubMed ID: 3631947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-lactam antibiotic sensitivity in Aeromonas spp. of clinical, animal, and environmental origin].
    Benassi FO; Vergara M; von Specht MH; García MA; Quiroga MI; Pucciarelli AB; Zubreski E; Laczeski M; Martin BM; Leardini N; Gutkind G
    Rev Argent Microbiol; 2001; 33(1):47-51. PubMed ID: 11407020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.
    Motyl MR; McKinley G; Janda JM
    Antimicrob Agents Chemother; 1985 Jul; 28(1):151-3. PubMed ID: 4037775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity of β-lactamases among clinical Aeromonas isolates and its clinical implications.
    Chen PL; Ko WC; Wu CJ
    J Microbiol Immunol Infect; 2012 Dec; 45(6):398-403. PubMed ID: 23031536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of the Vitek AutoMicrobic system to detect beta-lactam resistance in Aeromonas species.
    Schadow KH; Giger DK; Sanders CC
    Am J Clin Pathol; 1993 Sep; 100(3):308-10. PubMed ID: 8379542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic characterization and discrimination of Aeromonas species recovered from meat and water samples with a spotlight on the antimicrobial resistance of Aeromonas hydrophila.
    Elbehiry A; Marzouk E; Abdeen E; Al-Dubaib M; Alsayeqh A; Ibrahem M; Hamada M; Alenzi A; Moussa I; Hemeg HA
    Microbiologyopen; 2019 Nov; 8(11):e782. PubMed ID: 30614207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and phenotypic and genotypic detection of a metallo-β-lactamase, CphA, among bacteraemic Aeromonas isolates.
    Wu CJ; Chen PL; Wu JJ; Yan JJ; Lee CC; Lee HC; Lee NY; Chang CM; Lin YT; Chiu YC; Ko WC
    J Med Microbiol; 2012 May; 61(Pt 5):712-719. PubMed ID: 22322339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
    Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
    Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.